A. Veerman

16.0k total citations
302 papers, 11.6k citations indexed

About

A. Veerman is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, A. Veerman has authored 302 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Public Health, Environmental and Occupational Health, 91 papers in Pediatrics, Perinatology and Child Health and 74 papers in Hematology. Recurrent topics in A. Veerman's work include Acute Lymphoblastic Leukemia research (166 papers), Childhood Cancer Survivors' Quality of Life (76 papers) and Acute Myeloid Leukemia Research (54 papers). A. Veerman is often cited by papers focused on Acute Lymphoblastic Leukemia research (166 papers), Childhood Cancer Survivors' Quality of Life (76 papers) and Acute Myeloid Leukemia Research (54 papers). A. Veerman collaborates with scholars based in Netherlands, United States and Indonesia. A. Veerman's co-authors include Rob Pieters, Gertjan J.L. Kaspers, Marlies Vaz Nunes, Sutaryo Sutaryo, Elisabeth R. van Wering, Monique L. den Boer, K. Hählen, Leo de Sonneville, D. R. Huismans and R. Pieters and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

A. Veerman

291 papers receiving 11.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Veerman Netherlands 64 5.5k 3.4k 3.1k 3.0k 2.1k 302 11.6k
Jerome F. Strauss United States 83 7.1k 1.3× 3.1k 0.9× 9.5k 3.1× 660 0.2× 1.0k 0.5× 385 26.7k
Zev Rosenwaks United States 77 11.8k 2.1× 6.3k 1.9× 6.0k 2.0× 859 0.3× 926 0.4× 695 23.7k
David Robertson Australia 74 4.0k 0.7× 723 0.2× 7.8k 2.5× 317 0.1× 2.1k 1.0× 366 18.3k
John H. Kersey United States 61 2.3k 0.4× 893 0.3× 3.7k 1.2× 4.4k 1.5× 2.6k 1.3× 207 12.8k
D. Stephen Charnock‐Jones United Kingdom 76 1.6k 0.3× 4.8k 1.4× 6.7k 2.2× 380 0.1× 1.2k 0.6× 308 18.8k
Lucio Luzzatto United Kingdom 67 1.2k 0.2× 4.3k 1.3× 3.7k 1.2× 3.7k 1.2× 872 0.4× 364 16.5k
Daniel Sinnett Canada 51 2.5k 0.4× 1.7k 0.5× 3.7k 1.2× 723 0.2× 1.2k 0.6× 296 8.8k
Mel Greaves United Kingdom 57 6.0k 1.1× 2.7k 0.8× 5.6k 1.8× 5.0k 1.7× 2.8k 1.4× 167 13.8k
John Bradley United Kingdom 41 1.6k 0.3× 449 0.1× 1.0k 0.3× 1.7k 0.6× 1.1k 0.5× 246 9.3k
D. Niethammer Germany 52 2.0k 0.4× 1.2k 0.4× 2.2k 0.7× 3.8k 1.3× 2.3k 1.1× 289 9.0k

Countries citing papers authored by A. Veerman

Since Specialization
Citations

This map shows the geographic impact of A. Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Veerman more than expected).

Fields of papers citing papers by A. Veerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Veerman. The network helps show where A. Veerman may publish in the future.

Co-authorship network of co-authors of A. Veerman

This figure shows the co-authorship network connecting the top 25 collaborators of A. Veerman. A scholar is included among the top collaborators of A. Veerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Veerman. A. Veerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutaryo, Sutaryo, Sri Mulatsih, Eddy Supriyadi, et al.. (2022). Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower‐middle‐income country. Pediatric Blood & Cancer. 69(11). e29875–e29875. 7 indexed citations
2.
Veerman, A., Eddy Supriyadi, & Sutaryo Sutaryo. (2020). Developing leukemia protocols in cooperation between the Netherlands and Indonesia. SHILAP Revista de lepidopterología. 5(1). 7–10. 3 indexed citations
3.
Pluijm, Saskia M.F., M.L. te Winkel, Hester A. de Groot‐Kruseman, et al.. (2015). Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia. Haematologica. 100(12). 1564–1570. 20 indexed citations
4.
Pluijm, Saskia M.F., Hester A. de Groot‐Kruseman, M.L. te Winkel, et al.. (2014). The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia. Haematologica. 100(1). 62–69. 38 indexed citations
5.
Supriyadi, Eddy, A. Veerman, Yetty Movieta Nency, et al.. (2011). Immunophenotypic patterns of childhood acute leukemias in Indonesia.. PubMed. 12(12). 3381–7. 7 indexed citations
6.
Kamps, W. A., K.M. van der Pal‐de Bruin, A. Veerman, et al.. (2009). Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia. 24(2). 309–319. 81 indexed citations
7.
Grotel, Martine van, Jules P.P. Meijerink, Elisabeth R. van Wering, et al.. (2007). Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia. 22(1). 124–131. 91 indexed citations
8.
Veerman, A. & P.H.J.F. van den Boogert. (2003). Inventarisatie van nieuwe en bestaande mogelijkheden voor de bestrijding van schurft in aardappelen. Socio-Environmental Systems Modeling. 2003. 1 indexed citations
9.
Kearns, Pamela, Zofia M. Chrzanowska‐Lightowlers, Rob Pieters, A. Veerman, & Andrew G. Hall. (2002). Mu class glutathione S‐transferase mRNA isoform expression in acute lymphoblastic leukaemia. British Journal of Haematology. 120(1). 80–88. 21 indexed citations
10.
Tellegen, Peter, et al.. (2002). Neuropsychologic assessment of newly diagnosed children with acute lymphoblastic (all) and their sibling during early hospitalisation.. University of Groningen research database (University of Groningen / Centre for Information Technology). 277–277.
11.
Veerman, A., et al.. (2001). Toetsing van de effectiviteit van een warmwaterbehandeling tegen zilverschurft in aardappelen. Socio-Environmental Systems Modeling.
12.
Roberts, Stefan G. E., et al.. (2000). CALENDAR. British Journal of Cancer. 83(11). 1582–1582. 1 indexed citations
13.
Släter, R, et al.. (1999). T(7;12)(q36;p13) - A new translocation involving ETV6 associated with a poor prognosis in myeloid malignancies of very young children. Data Archiving and Networked Services (DANS). 1 indexed citations
14.
Veerman, A., et al.. (1998). Childhood acute lymphoblastic leukemia in the Netherlands - Randomized studies and nationwide treatment results from 1972 to 1995. 5. 125–139. 6 indexed citations
15.
Pieters, R., Gertjan J.L. Kaspers, & A. Veerman. (1997). Drug resistance culture assays in childhood leukemia. A review of the results and applications. Pure Amsterdam UMC. 4(6). 531–541. 1 indexed citations
16.
Kaspers, Gertjan J.L., R. Pieters, & A. Veerman. (1997). Glucocorticoid resistance in childhood leukemia. Pure Amsterdam UMC. 4(6). 583–596. 6 indexed citations
17.
Gemke, Reinoud J. B. J., Krijn Haasnoot, & A. Veerman. (1989). Early onset agammaglobulinaemia with monoclonal IgG production. European Journal of Pediatrics. 148(8). 755–757. 1 indexed citations
18.
Pieters, Rob, et al.. (1989). OSTEONECROSIS FOLLOWING CHEMOTHERAPY FOR LEUKEMIA. European Journal Of Haematology. 43(3). 262–264. 6 indexed citations
19.
Pieters, Rob, D. R. Huismans, A. Leyva, & A. Veerman. (1988). Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. Cancer Letters. 41(3). 323–332. 124 indexed citations
20.
Baan, S. van der, A. Veerman, Evert F. Weltevreden, & L. Feenstra. (1982). [Primary ciliary dyskinesia; ciliary activity and ultrastructure in 11 patients with Kartagener syndrome].. PubMed. 126(52). 2376–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026